These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26502013)

  • 21. Rosai-Dorfman disease.
    Bist SS; Bisht M; Varshney S; Kishore S
    Ear Nose Throat J; 2008 Jan; 87(1):16-7. PubMed ID: 18357937
    [No Abstract]   [Full Text] [Related]  

  • 22. Dural-based Rosai-Dorfman disease: differential diagnostic considerations.
    Prayson RA; Rowe JJ
    J Clin Neurosci; 2014 Nov; 21(11):1872-3. PubMed ID: 25281034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous Rosai-Dorfman disease.
    Merola JF; Pulitzer M; Rosenman K; Brownell I
    Dermatol Online J; 2008 May; 14(5):8. PubMed ID: 18627744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended treatment response to imatinib in Rosai-Dorfman disease.
    Singh A; Simons Y; Biren-Fetz J; Mohapatra G; Ni H; Gaitonde S; Khan I
    Eur J Haematol; 2021 Jun; 106(6):868-870. PubMed ID: 33619765
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.
    Saboo SS; Jagannathan JP; Krajewski KM; O'Regan K; Hornick JL; Fisher DC; Ramaiya N
    J Clin Oncol; 2011 Nov; 29(31):e772-5. PubMed ID: 21931038
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous Rosai-Dorfman disease accompanied by Langerhans cell hyperplasia responsive to combined treatment.
    Wei J; Zhang Y; Jin J; Zhang J
    Chin Med J (Engl); 2014; 127(17):3200. PubMed ID: 25189975
    [No Abstract]   [Full Text] [Related]  

  • 29. Rosai-Dorfman disease (extranodal sinus histiocytosis) in a patient with HIV.
    Perry BP; Gregg CM; Myers S; Lilly S; Mann KP; Prieto V
    Ear Nose Throat J; 1998 Oct; 77(10):855-8. PubMed ID: 9818538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X; Aulagner G; Facon T
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of disseminated Rosai-Dorfman disease with siltuximab.
    Lee H; King G; Garg K; Pan Z; Tobin J; Robinson WA
    Haematologica; 2018 Jul; 103(7):e325-e328. PubMed ID: 29599203
    [No Abstract]   [Full Text] [Related]  

  • 32. Facial Cutaneous Rosai-Dorfman Disease.
    Flores-Terry MÁ; Romero-Aguilera G; González-López L; García-Arpa M
    Actas Dermosifiliogr; 2017 Jun; 108(5):480-482. PubMed ID: 28109522
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient.
    Hinterleitner C; Steurer M; Dörfel D; Heitmann J; Kreisselmeier KP; Müller K; Kopp HG; Wirths S; Haap M; de Fend LQ; Horger M; Rodriguez-Galindo C; Kanz L; Müller MR
    Ann Hematol; 2019 Jan; 98(1):227-230. PubMed ID: 29980874
    [No Abstract]   [Full Text] [Related]  

  • 34. Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
    Chan CC; Chu CY
    Arch Dermatol; 2006 Apr; 142(4):428-30. PubMed ID: 16618860
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rosai-Dorfman disease revealed by renal failure: case report].
    Laboudi A; Haouazine N; Benabdallah L; Arzouk N; Cherradi N; Rhou H; Benamar L; Ezaitouni F; Ouzeddoun N; Hamani Z; Balafrej L
    Nephrologie; 2001; 22(2):53-6. PubMed ID: 11385902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of lenalidomide in treating refractory prurigo nodularis.
    Liu H; Gaspari AA; Schleichert R
    J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosai Dorfman disease--a clinico-pathological presentation.
    Mehrotra S; Ather S; Gupta P; Mehrotra B
    J Assoc Physicians India; 2007 Aug; 55():587-9. PubMed ID: 18019802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosai Dorfman disease--a rare entity report of two cases with nodal and extranodal involvement.
    Jalil J; Dar NR; Shafique M
    J Pak Med Assoc; 2008 Jun; 58(6):338-40. PubMed ID: 18988397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide and lenalidomide in multiple myeloma.
    Mazumder A; Jagannath S
    Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosai-Dorfman disease with extranodal manifestation in the head.
    Sennes L; Koishi H; Cahali R; Sperandio F; Butugan O
    Ear Nose Throat J; 2004 Dec; 83(12):844-7. PubMed ID: 15724744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.